@article{406500565a8a426c82f267cb53dfd944,
title = "Response to Gwozdz and colleagues",
author = "Ido Weinberg and Jaff, {Michael R.} and Suresh Vedantham",
note = "Funding Information: https://orcid.org/0000-0003-4633-5132 Weinberg Ido 1 Jaff Michael R 2 Vedantham Suresh 3 1 Vascular Medicine, Massachusetts General Hospital, Boston, MA, USA 2 Administration, Harvard Medical School, Newton-Wellesley Hospital, Newton, MA, USA 3 Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO, USA Ido Weinberg, Vascular Medicine, Massachusetts General Hospital, 55 Fruit St, GB 800, Boston, MA 02114, USA. Email: iweinberg@partners.org 11 2019 1358863X19882743 {\textcopyright} The Author(s) 2019 2019 SAGE Publications edited-state corrected-proof Declaration of conflicting interests The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: IW – none; MRJ – holds equity in Embolitech and Venarum; uncompensated advisor: Boston Scientific, Cordis Corporation; compensated advisor: Medtronic, Sanofi, BTG; consultant: Volcano/Phillips; SV – grant support from Cook Medical. Funding The authors received no financial support for the research, authorship, and/or publication of this article. ORCID iD Ido Weinberg https://orcid.org/0000-0003-4633-5132 ",
year = "2020",
month = feb,
day = "1",
doi = "10.1177/1358863X19882743",
language = "English",
volume = "25",
pages = "90--91",
journal = "Vascular Medicine",
issn = "1358-863X",
number = "1",
}